Value proposition
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and MedtechOriginal language
Our Vision : We have High Standards - We Build Companies - We have Impact
Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2).
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
Kurma Partners - Major player in the funding of healthcare and biotechnology in Europe
https://www.kurmapartners.com/en
| Entity | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Ysios Capital Venture Capital and Private Equity Principals | Other 12 May 2024 | | |
 | Tiendanimal Retail, retail, pettech | Other 3 May 2018 | | |
 | Asabys Partners Venture Capital and Private Equity Principals | Other 28 Feb 2023 | | |
 | Inserm Transfert Biotechnology Research | Other 25 Jun 2021 | | |
 | Orano Med Biotechnology Research, biotech, deeptech | Other 19 Nov 2022 | | |
 | Groupe Pasteur Mutualité Insurance, healthtech | Other 28 Feb 2022 | | |
 | JEITO Venture Capital and Private Equity Principals | Other 28 Apr 2021 | | |
 | Poppins Medical Equipment Manufacturing, edtech | Other 19 Dec 2022 | | |
 | Health Innovation Port Medical Equipment Manufacturing, healthtech | Other 15 Nov 2022 | | |
 | Amolyt Pharma Biotechnology Research, biotech, deeptech | Other 19 Jul 2024 | | |